Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Is FIB-4 the right tool for screening for liver fibrosis?
Leen JM. Heyens; Demi P.A.van Malde; Gediz Dogay Us; Francesco Innocenti; Mathieu Struyve; Christophe Van Steenkiste; Sven Francque; Geert Robaeys; Ger H. Koek;
10.1016/j.aohep.2025.102176
Liver stiffness measurement trajectory analysis for prognosis in patients with chronic hepatitis B and compensated advanced chronic liver disease
Hao Jiang; Hongsheng Yu; Can Hu; Yinan Huang; Bilan Yang; Xiaoli Xi; Yiming Lei; Bin Wu; Yidong Yang;
10.1016/j.aohep.2025.101788
Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018
Tongtong Wang; Yuzhi Xi; Annaswamy Raji; Michael Crutchlow; Gail Fernandes; Samuel S Engel; Xiao Zhang;
Ann Hepatol. 2024;29: